Work

Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation

Year: 2013

Type: article

Abstract: Toxicity associated with the hematopoietic stem cell transplant (HSCT) process commonly results in a need for critical care resources. Identifying biomarkers associated with critical illness in HSCT patients may improve outcomes. Brain natriuretic peptide (BNP) has become a useful marker of cardiopulmonary disease in many settings. The value of BNP levels early in the HSCT process in children is largely unknown.

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2012.11.345

Authors: Rajinder Bajwa, Jennifer McArthur, Julie-An Talano, Julie Fitzgerald, Christine Duncan, Steven Margossian, Andrew Yates, Mark Hall, Susan Cunnigham, Debbie Spear, Katherine Luther, Robert Tamburro

Institutions: Nationwide Children's Hospital, Medical College of Wisconsin, Children's Hospital of Wisconsin, Children's Hospital of Pittsburgh, Dana-Farber Cancer Institute, Boston Children's Hospital, Pennsylvania State University, Penn State Milton S. Hershey Medical Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650

OpenAlex ID: W2096954945

FWCI:

Cites:

Cited by:

Related to: 10